How should a patient with restless‑legs syndrome be managed during anesthesia and the peri‑operative period?

Management of Restless Legs Syndrome During Anesthesia and Perioperative Period

Continue the patient's home RLS medications throughout the perioperative period whenever possible, using parenteral formulations if oral intake is restricted, and aggressively avoid dopamine antagonists, serotonergic agents, and opioid antagonists during anesthesia. 1, 2, 3

Preoperative Preparation

Medication Continuation Strategy

• Maintain existing RLS therapy through surgery—abrupt discontinuation triggers severe exacerbations 2, 3
• For patients on gabapentin, gabapentin enacarbil, or pregabalin (the AASM's strongest recommendations 4):
  • Continue oral dosing up to 2 hours preoperatively with sip of water
  • If NPO status prohibits oral intake, consider IV gabapentin if available or bridge with parenteral opioids
• For patients on dopamine agonists (pramipexole, ropinirole, rotigotine):
  • Despite AASM suggesting against standard use due to augmentation risk 4, these patients are already on therapy
  • Continue their established regimen—withdrawal causes severe rebound 3
  • Rotigotine patches can remain in place throughout surgery
  • Consider temporary dose increase postoperatively if symptoms worsen 3

Iron Status Assessment

• Check ferritin and transferrin saturation preoperatively in all RLS patients 4
• Avoid excessive phlebotomy—blood loss worsens RLS 2, 3
• If iron deficient (ferritin <75 ng/mL, TSAT <20%), consider preoperative IV iron repletion with ferric carboxymaltose (AASM strong recommendation) 4

Intraoperative Management

Critical Drug Avoidance

Absolutely contraindicate these medications as they precipitate severe RLS exacerbations 1, 3:

• Dopamine antagonists: droperidol, metoclopramide, prochlorperazine, promethazine
• Antihistamines with dopamine effects: hydroxyzine, diphenhydramine
• Serotonergic agents: ondansetron is generally safe, but avoid excessive doses
• Opioid antagonists: avoid naloxone unless absolutely necessary

Preferred Anesthetic Agents

• No specific anesthetic technique (general vs. regional) has been shown to worsen RLS 1
• Opioids are beneficial—use remifentanil, fentanyl, or sufentanil liberally during anesthesia 1, 3
• Dexmedetomidine may be protective—one case report showed dramatic symptom improvement at 0.4 μg/kg/h 5
• Propofol, sevoflurane, and other standard agents appear neutral 5

Postoperative Management

Immediate Recovery Period

RLS symptoms typically worsen 12-48 hours postoperatively due to forced immobilization, sleep deprivation, and surgical stress 1, 2, 3. Watch for:

• Inability to remain still in bed
• Severe leg discomfort described as crawling, pulling, or aching
• Agitation and akathisia that mimics delirium
• Symptoms spreading to arms (occurs in severe exacerbations) 5
• Suicidal ideation from intolerable discomfort 3

Acute Symptom Management

If severe exacerbation occurs:

1. First-line: IV or subcutaneous opioids (morphine, hydromorphone, oxycodone) 3

   • AASM conditionally recommends opioids for RLS 4
   • Provides immediate relief while addressing underlying triggers

2. Second-line: Benzodiazepines (lorazepam, clonazepam) 3

   • Though AASM suggests against clonazepam for chronic RLS 4, it helps acute perioperative exacerbations
   • Useful for associated insomnia and anxiety

3. Consider dexmedetomidine infusion (0.2-0.4 μg/kg/h) if symptoms persist 5

4. Temporarily increase home dopamine agonist dose if patient was on these agents 3

Resuming Oral Medications

• Restart gabapentin/pregabalin at home dose as soon as oral intake tolerated 4
• Resume dopamine agonists at previous dose (or slightly higher if severe exacerbation) 3
• Taper any bridging opioids once home medications re-established

Non-Pharmacologic Interventions

• Encourage early mobilization—walking provides immediate symptom relief 5, 2
• Allow frequent position changes and leg movements in bed 2
• Avoid prolonged bed rest beyond medical necessity 2
• Apply cold or warm compresses to legs (patient preference varies)
• Pneumatic compression devices may help or worsen symptoms—trial individually

Special Populations

End-Stage Renal Disease Patients with RLS

• Gabapentin remains first-line (conditional recommendation) 4
• IV iron sucrose if ferritin <200 ng/mL and TSAT <20% (conditional recommendation) 4
• Adjust gabapentin dosing for renal function
• These patients have higher RLS prevalence and severity

Pregnancy

• RLS worsens in third trimester and peripartum period 1
• Iron supplementation is safest intervention
• Avoid dopamine agonists
• Opioids acceptable for acute perioperative management

Common Pitfalls

1. Mistaking RLS exacerbation for postoperative delirium or anxiety—leads to inappropriate treatment with antipsychotics that worsen symptoms 3

2. Using antiemetics that block dopamine—metoclopramide and droperidol are particularly problematic 1, 3

3. Discontinuing home RLS medications perioperatively—causes predictable severe rebound 2, 3

4. Excessive phlebotomy—each blood draw worsens iron deficiency and RLS 2, 3

5. Prolonged immobilization—enforce early mobilization protocols 2

The evidence base for perioperative RLS management comes primarily from case reports and expert opinion [6-3], as the 2025 AASM guidelines [4-4] focus on chronic outpatient treatment rather than acute perioperative scenarios. However, the principles are clear: maintain existing therapy, avoid dopamine antagonists, use opioids liberally, and promote early mobilization.